Accuray Also Announces Chief Financial Officer, Ali Pervaiz SUNNYVALE, Calif. , April 27, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that Suzanne Winter , President, will succeed Joshua Levine as the company's Chief Executive Officer, effective July 1, 2022 . Mr.
SUNNYVALE, Calif. , April 27, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) today reported financial results for the third quarter of fiscal 2022 ended March 31, 2022 . Third Quarter Fiscal 2022 Summary Gross orders of $88.6 million , an increase of 1 percent compared to the prior
SUNNYVALE, Calif. , April 21, 2022 /PRNewswire/ -- When Al Gold , the owner of the Arkansas Derby winner Cyberknife, received a diagnosis of prostate cancer, he was determined to find a potential cure for his disease while minimizing the impact of treatment on his daily life. Mr.
SUNNYVALE, Calif. , April 13, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) will report financial results for the third quarter of fiscal year 2022, ended March 31, 2022, after the market close on April 27, 2022. Management will host a conference call to review the results at 1:30 p.m.
Study Abstract Recognized as Best Clinical Abstract at 2022 Radiosurgical Society Meeting SUNNYVALE, Calif. , March 31, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that long-term follow-up data from a study of men and women with trigeminal neuralgia (TN) showed 72
CARTI is First in Arkansas to Treat Patients with World's Only Robotic Radiosurgery System SUNNYVALE, Calif. , March 8, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the CARTI medical care team in Little Rock, Arkansas has treated the first patients in the state
Robotic Radiosurgery System Provides Effective, Non-invasive Treatment Option for this Chronic Pain Condition, Typically Delivered in Just One Out-Patient Procedure SUNNYVALE, Calif. , Feb. 28, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today that the National Institute for
Company to Take Part in Fireside Chat Monday, March 7, 2022 at 9:50am PST / 12:50pm EST SUNNYVALE, Calif. , Feb. 24, 2022 /PRNewswire/ -- Accuray Incorporated (NASDAQ: ARAY) announced today its participation in the Cowen 42nd Annual Health Care Conference taking place March 7-9, 2022 .
- Royal Brisbane and Women's Hospital acquisition is intended to expand access to potentially life-saving radiotherapy treatments to more patients - Hospital was the first in Australia to invest in the TomoTherapy® helical radiotherapy delivery platform and is now the first to secure the latest
- Phase III, randomized controlled trial results highlight patient reported outcomes at 10 years'follow-up - TomoTherapy delivered hypofractionated radiotherapy was superior to conventional radiotherapy in maintaining patients' heart and lung functioning, enabling them to more easily perform daily
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
